Live Breaking News & Updates on Complications trial

Stay informed with the latest breaking news from Complications trial on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Complications trial and stay connected to the pulse of your community

CGM Use May Reduce Likelihood of Diabetic Retinopathy in T1D

This finding on continuous glucose monitoring (CGM) remained even after the researchers adjusted for glycemic control according to HbA1C levels.

United-states , American , American-diabetes-association , African-american , Area-deprivation-index , Diabetes-control , Complications-trial ,

Neuropathic Pain Presents Without Neuropathy Clinical Signs in Type 1 Diabetes

Neuropathic pain presented frequently and without clinical signs of neuropathy among individuals with type 1 diabetes, especially women.

Michigan , United-states , Diabetes-control , Complications-trial , Diabetes-interventions , Michigan-neuropathy-screening-instrument ,

Neuropathic Pain Presents Without Neuropathy Clinical Signs in Type 1 Diabetes

Neuropathic pain presented frequently and without clinical signs of neuropathy among individuals with type 1 diabetes, especially among women.

Michigan , United-states , Diabetes-control , Complications-trial , Diabetes-interventions , Michigan-neuropathy-screening-instrument , Hispanic-white ,

6 Facts About Time in Range and the Glucose Management Indicator

A thorough understanding of continuous glucose monitor metrics will assist clinicians with medical management decisions.

United-states , American , Americans , American-diabetes-association , National-hospital-ambulatory-medical-care , National-ambulatory-medical-care , National-ambulatory-medical-care-survey , Black-americans , Associated-with , Diabetes-control , Complications-trial

New advances in type 1 diabetes

Type 1 diabetes is an autoimmune condition resulting in insulin deficiency and eventual loss of pancreatic β cell function requiring lifelong insulin therapy. Since the discovery of insulin more than 100 years ago, vast advances in treatments have improved care for many people with type 1 diabetes. Ongoing research on the genetics and immunology of type 1 diabetes and on interventions to modify disease course and preserve β cell function have expanded our broad understanding of this condition. Biomarkers of type 1 diabetes are detectable months to years before development of overt disease, and three stages of diabetes are now recognized. The advent of continuous glucose monitoring and the newer automated insulin delivery systems have changed the landscape of type 1 diabetes management and are associated with improved glycated hemoglobin and decreased hypoglycemia. Adjunctive therapies such as sodium glucose cotransporter-1 inhibitors and glucagon-like peptide 1 receptor agonists may find use in management in the future. Despite these rapid advances in the field, people living in under-resourced parts of the world struggle to obtain necessities such as insulin, syringes, and blood glucose monitoring essential for managing this condition. This review covers recent developments in diagnosis and treatment and future directions in the broad field of type 1 diabetes.

United-states , Netherlands , United-kingdom , Germany , Canada , Hungary , American , Farah-khan , Savitha-subramanian , International-diabetes-federation , International-hypoglycemia-study-group , National-institute-for-health

Shattering myths: Study reveals new insights on type 1 diabetes and obesity link

Review examines the relationship between type 1 diabetes and weight disorders, debunking myths about T1D and offering recommendations for future research and therapeutic interventions.

United-states , Canada , India , International-journal-of-obesity , Diabetes-exchange , International-journal , Monkey-business , Diabetes-patienten-verlaufsdokumentation , Diabetes-control , Complications-trial , United-kingdom-based

Helping your child with diabetes avoid heart problems

Cardiovascular disease is one of the many complications that can result from poorly-controlled diabetes.

Malaysia , International-diabetes-federation-atlas , International-diabetes-federation , Diabetes-control , Complications-trial , Diabetes-complications , Children , Hormones-and-kids , Child-health , Diabetes , Non-communicable-diseases

Connection Between Diabetes And Eye Health: How To Manage Diabetic Retinopathy

Diabetic retinopathy is a condition where elevated blood sugar levels cause damage to the blood vessels in the retina. Read on to know its symptoms and risk factors.

Avnish-deshmukh , Better-eye-health , Facebook , Relationship-between-coffee-and-eye-health , Youtube , Twitter , Winter-health , Diabetic-retinopathy , Breaking-news , Detection-of-diabetic-retinopathy , Factors-of-diabetic-retinopathy

Novo Nordisk Soars To New High On Weight-Loss Drug Trial Results

Novo Nordisk Soars To New High On Weight-Loss Drug Trial Results
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United-states , American , America , Novo-nordisk , Lilly-mounjaro , Eli-lilly , Martin-holst-lange , American-heart-association , Qualified-financial-advisor , Looks-good-for-eli-lilly , Changer-for-payor-debate , Diabetes-control

Novo Nordisk Soars To New High On Weight-Loss Drug Trial Results - Novo Nordisk (NYSE:NVO), Eli Lilly (NYSE:LLY)

Weight-loss drugs are the pharmaceutical industry's equivalent of AI, in the sense of being a product with the capability to send shares soaring.

United-states , America , American , Martin-holst-lange , Novo-nordisk , Eli-lilly , Marketbeat-novo-nordisk , Lilly-mounjaro , American-heart-association , Eli-lilly-co , Diabetes-control , Complications-trial